Nonmedical Use of Xtampza^® ER and Other Oxycodone Medications in Adults Evaluated for Substance Abuse Treatment: Real-World Data from the Addiction Severity Index-Multimedia Version (ASI-MV^®).

While all quarterly rates of past 30-day NMU adjusted for the volume of ASI-MV assessments and almost all drug utilization adjusted rates were lowest for Xtampza ER, many did not reach statistical significance likely due to the small number of Xtampza ER NMU cases reported (n=73) and low volume of prescriptions and units dispensed, particularly during introduction of the product to the market.

also in 111,027 other papers